https://www.selleckchem.com/pr....oducts/poziotinib-hm
In the group of 24 HIV-positive patients, there were no early complications, and the mean HHS was 88 (range, 76 to 91) at 10 years. Conclusions Our 10-year experience and long-term outcomes after primary THA in a low-income setting show that good results can be achieved within a controlled hospital environment, thereby establishing a benchmark against which other hospitals and registries in similar low-income countries can compare their results. Level of Evidence Therapeutic Level IV. See Instructions for Authors for a